SCHEMBL4632775

SCHEMBL4632775

CC(=O)C(C)Cc1ccc(CBr)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.42
ESR2 Q92731 1/20 0.42
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
PTGS1 P23219 3/20 0.39
PTGS2 P35354 3/20 0.39
LMNA P02545 2/20 0.39
CYP2C9 P11712 2/20 0.39
AKR1C3 P42330 2/20 0.39
CXCR1 P25024 2/20 0.39
CXCR2 P25025 2/20 0.39
TSHR P16473 2/20 0.39
ALB P02768 1/20 0.39
ALOX5 P09917 1/20 0.39
RARB P10826 1/20 0.39
ADRB3 P13945 1/20 0.39
NFKB1 P19838 1/20 0.39
HTR2A P28223 1/20 0.39
NR1I3 Q14994 1/20 0.39
SLC22A6 Q4U2R8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9293068 0.89 ESR1 (0.48) ESR1ESR2PTGS1PTGS2LMNA
SCHEMBL22235331 0.84 KMT2A (0.53) ESR1ESR2MEN1NPC1RAB9A
SCHEMBL28031596 0.84 TBXAS1 (0.51) ESR1CES2CES1PTGS1PTGS2
SCHEMBL12229428 0.82 ESR1 (0.61) ESR1ESR2
SCHEMBL12794955 0.82 ACACB (0.50) ESR1ESR2PTGS1PTGS2LMNA
SCHEMBL7600582 0.82 ESR1 (0.61) ESR1ESR2
SCHEMBL14499001 0.82 ACACB (0.50) ESR1ESR2PTGS1PTGS2LMNA
SCHEMBL8062337 0.82 ACACB (0.50) ESR1ESR2PTGS1PTGS2LMNA
SCHEMBL18698817 0.82 ACACB (0.50) ESR1ESR2PTGS1PTGS2LMNA
SCHEMBL14019341 0.80 CYP1A2 (0.48) ESR1ESR2PTGS1PTGS2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1924561-A2 6-ARYLALKYLAMINO- 2,3,4,5-TETRAHYDRO-1H-BENZO[D]AZEPINES AS 5-HT2C RECEPTOR AGONISTS Eli Lilly & Company (US) 2008-05-28 EP disclosed
WO-2007028083-A2 6-ARYLALKYLAMINO- 2,3,4,5-TETRAHYDRO-1H-BENZO[D]AZEPINES AS 5-HT2C RECEPTOR AGONISTS ELI LILLY AND COMPANY (US) 2007-03-08 WO disclosed